Kumar Rakesh, Pandey Hem Chandra, Jain Romesh, Coshic Poonam, Jain Pankaj
Main Blood Bank, Department of Transfusion Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110029, India.
Main Blood Bank, Department of Transfusion Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi - 110029, India.
Transfus Apher Sci. 2020 Aug;59(4):102814. doi: 10.1016/j.transci.2020.102814. Epub 2020 May 13.
Treponemal tests provide advantage of better detection during early, late and latent stages of syphilis with equal or higher sensitivity & specificity in comparison to non-treponemal tests. The objective of the present study was to analyse the level of concordance between treponemal and non-treponemal tests for donor screening and to correlate them with donor history.
Retrospective analysis of syphilis screening by treponemal (Chemiluminescence & TPHA) and non-treponemal tests (RPR) was done and donor history for high-risk behaviour and factors associated with false positivity were collected from post-donation counselling and collected data was coded and analysed.
Amongst the 12,000 donors screened, reactivity rate by RPR, TPHA and Chemiluminescence was 0.45%, 0.8% and 1.17% respectively. There was discordance of 62% and 32% for reactive results by RPR and TPHA respectively when compared with Chemiluminescence. History of high-risk behaviour was present in ∼ 50% and 15% of donors with discordant results by RPR and TPHA respectively. Of 34 donors who were reactive only by Chemiluminescence and were followed up, 15% had history of high-risk behaviour and 56% had factors associated with false reactivity.
Treponemal tests showed high syphilis reactivity amongst blood donors as compared to non-treponemal tests most likely due to their ability to detect early, late and latent syphilis cases. This may confer added transfusion safety in centres dependent on replacement donors without NAT testing by identifying donors with high-risk history with negligible increase in discard rate due to false reactivity.
与非梅毒螺旋体检测相比,梅毒螺旋体检测在梅毒的早期、晚期和潜伏期具有更好的检测优势,其敏感性和特异性相同或更高。本研究的目的是分析梅毒螺旋体检测与非梅毒螺旋体检测在献血者筛查中的一致性水平,并将其与献血者病史相关联。
对梅毒螺旋体检测(化学发光法和梅毒螺旋体血细胞凝集试验)和非梅毒螺旋体检测(快速血浆反应素环状卡片试验)进行梅毒筛查的回顾性分析,并从献血后咨询中收集高危行为和与假阳性相关因素的献血者病史,对收集的数据进行编码和分析。
在筛查的12000名献血者中,快速血浆反应素环状卡片试验、梅毒螺旋体血细胞凝集试验和化学发光法的反应率分别为0.45%、0.8%和1.17%。与化学发光法相比,快速血浆反应素环状卡片试验和梅毒螺旋体血细胞凝集试验反应性结果的不一致率分别为62%和32%。快速血浆反应素环状卡片试验和梅毒螺旋体血细胞凝集试验结果不一致的献血者中,分别约有50%和15%有高危行为史。在仅化学发光法反应阳性并接受随访的34名献血者中,15%有高危行为史,56%有与假反应性相关的因素。
与非梅毒螺旋体检测相比,梅毒螺旋体检测在献血者中显示出较高的梅毒反应性,这很可能是由于其能够检测早期、晚期和潜伏梅毒病例。这可能会在依赖替代献血者且无核酸检测的中心提高输血安全性,通过识别有高危病史的献血者,因假反应性导致的废弃率增加可忽略不计。